Panzyga^® will no longer have requirements through NovoLogix^® for URMBT members with Blue Cross non-Medicare plans, starting Sept. 3

For dates of service on or after Sept. 3, 2021, we're updating the NovoLogix online tool to remove prior authorization, site of care and quantity limit requirements for Panzyga (immune globulin, human-ifas), HCPCS code J1599.

This change affects UAW Retiree Medical Benefits Trust members with Blue Cross non-Medicare plans.

As a reminder, we require prior authorization for Panzyga through the NovoLogix^® online tool for dates of service from July 12, 2021, through Sept. 2, 2021.

For additional information on requirements related to drugs covered under the medical benefit, refer to the document Medical Drug Management with Blue Cross for UAW Retiree Medical Benefit Trust PPO non-Medicare Members.

We'll update this list with the new information about these drugs prior to the effective date.

Posted: September 2021
Line of business: Blue Cross Blue Shield of Michigan